SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
SAGE Therapeutics is a clinical-stage biopharmaceutical company committed to developing and commercializing novel medicines to treat life-threatening, rare CNS disorders. SAGE's lead program, SAGE-547, is in clinical development for super-refractory status epilepticus and is the first of several compounds the company is developing in its portfolio of potential seizure medicines. SAGE's proprietary chemistry platform has generated multiple new compounds that target GABA A and NMDA receptors, which are broadly accepted as impacting many psychiatric and neurological disorders.
Recent Articles
- Zepbound Shows Promising Weight Loss Results Over Wegovy
- Valentina Shevchenko Triumphs at UFC 315 with Unstoppable Spirit
- RadNet's Q1 Financial Growth and Future Outlook
- Innovative Philanthropy: AB DAO and AB Charity Team Up
- LIS Technologies Joins Major Conference as Platinum Sponsor
- Transforming Marketing with Optimove Engage for Everyone
- Understanding the Potential Impact on Backblaze Investors
- Transforming Mining: How Hartcoin Empowers Daily Profits
- Celebrating Five Decades of China-EU Diplomatic Relations
- Xi's Prominent Role in Commemoration of Historical Victory
- Enhance Your Skin's Radiance with Beverly Hills MD's Solution
- Predicted Growth of Global Media Streaming Market to 2032
- Exploring the Growth of the Global Satellite Data Services Market
- Genius Group’s CEO Account Breached: Safety Measures in Place
- Celebrating Humanitarian Contributions at the Ellis Island Medal Ceremony
- Roanoke College Celebrates Bee Campus USA Certification
- Honoring the Legacy of Herschel Segal: DAVIDsTEA's Journey
- Lecomely Unveils Revolutionary AirEdge A3 Multi-Styler for All
- CHAGEE Launches Their First Modern Tea House in the U.S.
- Roanoke College Unveils Tribute to Enslaved Laborers
- Elliott's Board Change Proposal Supported by Glass Lewis
- AWDPI's Inspiring Journey at the United Nations for Gender Equality
- Growth Projections for the Precious Metals Market to 2032
- TCL CSOT to Showcase Next-Gen Display Technologies at SID 2025
- MyStonks Introduces Groundbreaking On-Chain Stock Trading
- Your Rights as a BBAI Investor and Legal Options Explained
- Understanding the enCore Energy Corp. Class Action Lawsuit
- Recognizing Middle East’s Unsung Heroes in Hospitality Engineering
- Abu Dhabi's Vision: Strengthening Ties with Japan for Growth
- Skyline Therapeutics Showcases Innovative Gene Therapy for Vision Restoration
- Strengthening Ties: Abu Dhabi's Economic Delegation Visits Japan
- Understanding the Cerevel Therapeutics Securities Litigation Process
- Projected Growth in Global Hotel Toiletries Market Until 2032
- Energy Storage Systems Show Strong Growth Potential Amid Trends
- JA Mining's $100 Welcome Bonus: A Gateway to Bitcoin Mining
- Dyness Shines at Intersolar Europe with Innovative Solutions
- Investors Offered Chance to Lead Bakkt Holdings Lawsuit
- Investigation Launched into Organon & Co. by Law Firm
- Luohu and Barcelona Forge a Path to Economic Cooperation
- Topband Leads Energy Innovation at The Smarter E Europe Event
- Insights from Akero's Phase 2b HARMONY Trial Analysis Unveiled
- HOOKII's Neomow X Revolutionizes Robotic Lawn Care Experience
- HOOKII Celebrates Kickstarter Triumph and Global Neomow X Launch
- Understanding the Allegations Against Compass Diversified Holdings
- Exploring the Growth of Healthcare Digital Twins Through 2032
- Celebrating Love: Wayfinder's Fundraiser Enhances Family Programs
- Global Paint Remover Market Growth Projections for 2032
- Merritt's Strategic Acquisition of Magnum Trailer & Equipment
- Exciting New Racing Championship by Harley-Davidson and MotoGP
- Madrigal Pharmaceuticals Reports Promising Two-Year Rezdiffra Results